On an international scale, it is the only tool that helps medical professionals assess the state of consciousness and to rehabilitate patients suffering from various neurological disorders.
C-Eye® II PRO is a medical product, which uses eye-tracking technology
It is a method which brings benefits to the patients and their therapists
Therapists who use the C-Eye® II PRO system can assess the condition of patients with neurological and developmental disorders, establish contact with them, and start rehabilitation according to their needs. Diagnostic and therapeutic sessions involve the patient performing special tasks, using their eyes. The tasks are displayed as various pictures on the screen. It is possible to examine and then stimulate particular centres in the central nervous system responsible for sight, hearing and cognitive functions.
Many professionals can use the device successfully in their work
The C-Eye® II PRO version is designed primarily for health care centres, such as hospitals, nursing homes, hospices, doctors and therapists (speech therapists, psychologists and trained caregivers). Wherever visual contact with patients is possible.
The C-Eye® II PRO system consists of the following parts:
C-Eye® II PRO system
The ordered C-Eye® II PRO system includes:
C-Eye® II PRO device
(with built-in eye tracking system)
Mobile stand PRO,
which makes mounting the device easier
C-Eye® II PRO is designed for medical professionals who work with the following groups of patients:
- Patients who suffered any type of brain injury (cerebral-cranial traumas, stroke, brain hypoxia and others). These are, in particular, patients after coma who have not yet recovered full consciousness, as well as patients in a minimally conscious state or vegetative state.
- Patients suffering from various neurological disorders which affect communication with the environment, including patients with quadriplegia cerebral palsy.
- Patients who are immobilized, fully conscious, have difficulties in communicating, including patients with aphasia, or dysarthria.
- Patients suffering from multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS).
- Elderly patients who have difficulties in communicating.
- Children with developmental disorders.